Szarvas T - Search Results

1

Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer.

Szarvas T, Reis H, Kramer G, Shariat SF, Vom Dorp F, Tschirdewahn S, Schmid KW, Kovalszky I, Rübben H. Szarvas T, et al. Hum Pathol. 2014 Apr;45(4):674-82. doi: 10.1016/j.humpath.2013.10.036. Epub 2013 Dec 18. Hum Pathol. 2014. PMID: 24656090

2

The presence of human papillomavirus 16 in neural structures and vascular endothelial cells.

Füle T, Máthé M, Suba Z, Csapó Z, Szarvas T, Tátrai P, Paku S, Kovalszky I. Füle T, et al. Among authors: szarvas t. Virology. 2006 May 10;348(2):289-96. doi: 10.1016/j.virol.2005.12.043. Epub 2006 Feb 24. Virology. 2006. PMID: 16499942 Free article.

3

[Use of silicon chip technology to detect protein-based tumor markers in bladder cancer].

Jäger T, Szarvas T, vom Dorp F, Börgermann C, Schenck M, Schmid KW, Rübben H. Jäger T, et al. Among authors: szarvas t. Urologe A. 2007 Sep;46(9):1152-6. doi: 10.1007/s00120-007-1429-z. Urologe A. 2007. PMID: 17593336 German.

4

Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.

Szarvas T, Kovalszky I, Bedi K, Szendroi A, Majoros A, Riesz P, Füle T, László V, Kiss A, Romics I. Szarvas T, et al. Oncol Rep. 2007 Aug;18(2):405-9. Oncol Rep. 2007. PMID: 17611663

5

Detection of bladder cancer from the urine using fluorescence in situ hybridization technique.

Riesz P, Lotz G, Páska C, Szendrôi A, Majoros A, Németh Z, Törzsök P, Szarvas T, Kovalszky I, Schaff Z, Romics I, Kiss A. Riesz P, et al. Among authors: szarvas t. Pathol Oncol Res. 2007;13(3):187-94. doi: 10.1007/BF02893498. Epub 2007 Oct 7. Pathol Oncol Res. 2007. PMID: 17922047 Free article.

6

Serum levels of angiogenic factors and their prognostic relevance in bladder cancer.

Szarvas T, Jäger T, Droste F, Becker M, Kovalszky I, Romics I, Ergün S, Rübben H. Szarvas T, et al. Pathol Oncol Res. 2009 Jun;15(2):193-201. doi: 10.1007/s12253-008-9107-z. Epub 2008 Sep 20. Pathol Oncol Res. 2009. PMID: 18807212 Free article.

7

[Role of lymphadenectomy in patients with invasive urothelial carcinoma of the bladder].

vom Dorp F, Börgermann C, Schenck M, Becker M, Rose A, Szarvas T, Rübben H. vom Dorp F, et al. Among authors: szarvas t. Urologe A. 2009 Jan;48(1):51-3. doi: 10.1007/s00120-008-1760-z. Urologe A. 2009. PMID: 19048222 Review. German.

8

Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.

Szarvas T, Jäger T, Tötsch M, vom Dorp F, Kempkensteffen C, Kovalszky I, Romics I, Ergün S, Rübben H. Szarvas T, et al. Clin Cancer Res. 2008 Dec 15;14(24):8253-62. doi: 10.1158/1078-0432.CCR-08-0677. Clin Cancer Res. 2008. PMID: 19088043

9

[Urine-based markers of angiogenesis in bladder cancer].

Becker M, Tilki D, Szarvas T, Rübben H, Ergün S. Becker M, et al. Among authors: szarvas t. Urologe A. 2009 Jun;48(6):609-14. doi: 10.1007/s00120-009-1989-1. Urologe A. 2009. PMID: 19557465 Review. German.

10

[Urine-based cytological diagnosis against the background of the new histopathological classification].

Tschirdewahn S, Boergermann C, Becker M, Szarvas T, Rübben H, vom Dorp F. Tschirdewahn S, et al. Among authors: szarvas t. Urologe A. 2009 Jun;48(6):615-8. doi: 10.1007/s00120-009-1990-8. Urologe A. 2009. PMID: 19557466 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters